$6.15
-0.18[-2.84%]
At close: Apr 25
$6.15
0[0.00%]
After Hours: 4:20PM EDT
Replimune Group
(NASDAQ:REPL)Replimune Group Stock (NASDAQ:REPL), Analyst Ratings, Price Targets, Predictions
Replimune Group Inc has a consensus price target of $44, established from looking at the 30 latest analyst ratings. The last 3 analyst ratings were released from Barclays, HC Wainwright & Co., and Wedbush on December 6, 2023, November 13, 2023, and November 8, 2023. With an average price target of $37.67 between Barclays, HC Wainwright & Co., and Wedbush, there's an implied 512.47% upside for Replimune Group Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
HC Wainwright & Co.
Wedbush
JP Morgan
EF Hutton
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Replimune Group
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/06/2023 | REPL | Buy Now | Replimune Group | $6.15 | 111.38% | Barclays | Peter Lawson | $50 → $13 | Maintains | Overweight | Get Alert |
| 11/13/2023 | REPL | Buy Now | Replimune Group | $6.15 | 680.49% | HC Wainwright & Co. | Robert Burns | $50 → $48 | Maintains | Buy | Get Alert |
| 11/08/2023 | REPL | Buy Now | Replimune Group | $6.15 | 745.53% | Wedbush | Robert Driscoll | → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | REPL | Buy Now | Replimune Group | $6.15 | 713.01% | HC Wainwright & Co. | Robert Burns | $51 → $50 | Maintains | Buy | Get Alert |
| 08/01/2023 | REPL | Buy Now | Replimune Group | $6.15 | 729.27% | HC Wainwright & Co. | Robert Burns | → $51 | Reiterates | Buy → Buy | Get Alert |
| 06/15/2023 | REPL | Buy Now | Replimune Group | $6.15 | 713.01% | JP Morgan | Anupam Rama | $38 → $50 | Maintains | Overweight | Get Alert |
| 06/08/2023 | REPL | Buy Now | Replimune Group | $6.15 | 729.27% | HC Wainwright & Co. | Robert Burns | → $51 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | REPL | Buy Now | Replimune Group | $6.15 | 745.53% | Wedbush | Robert Driscoll | → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2023 | REPL | Buy Now | Replimune Group | $6.15 | 875.61% | EF Hutton | Tony Butler | → $60 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | REPL | Buy Now | Replimune Group | $6.15 | 729.27% | HC Wainwright & Co. | Robert Burns | $50 → $51 | Maintains | Buy | Get Alert |
| 06/05/2023 | REPL | Buy Now | Replimune Group | $6.15 | 875.61% | EF Hutton | Tony Butler | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | REPL | Buy Now | Replimune Group | $6.15 | 875.61% | EF Hutton | Tony Butler | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2023 | REPL | Buy Now | Replimune Group | $6.15 | 745.53% | Wedbush | Robert Driscoll | → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 04/17/2023 | REPL | Buy Now | Replimune Group | $6.15 | 615.45% | Piper Sandler | Allison Bratzel | → $44 | Assumes | → Overweight | Get Alert |
| 02/10/2023 | REPL | Buy Now | Replimune Group | $6.15 | 713.01% | HC Wainwright & Co. | Robert Burns | $48 → $50 | Reiterates | → Buy | Get Alert |
| 01/05/2023 | REPL | Buy Now | Replimune Group | $6.15 | 875.61% | EF Hutton | Tony Butler | → $60 | Initiates | → Buy | Get Alert |
| 12/12/2022 | REPL | Buy Now | Replimune Group | $6.15 | 1038.21% | BMO Capital | Evan David Seigerman | $40 → $70 | Maintains | Outperform | Get Alert |
| 12/07/2022 | REPL | Buy Now | Replimune Group | $6.15 | 452.85% | SVB Leerink | Jonathan Chang | $30 → $34 | Maintains | Outperform | Get Alert |
| 11/04/2022 | REPL | Buy Now | Replimune Group | $6.15 | 680.49% | HC Wainwright & Co. | Robert Burns | $60 → $48 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Replimune Group (REPL)?
The latest price target for Replimune Group (NASDAQ: REPL) was reported by Barclays on December 6, 2023. The analyst firm set a price target for $13.00 expecting REPL to rise to within 12 months (a possible 111.38% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Replimune Group (REPL)?
The latest analyst rating for Replimune Group (NASDAQ: REPL) was provided by Barclays, and Replimune Group maintained their overweight rating.
When was the last upgrade for Replimune Group (REPL)?
There is no last upgrade for Replimune Group.
When was the last downgrade for Replimune Group (REPL)?
There is no last downgrade for Replimune Group.
When is the next analyst rating going to be posted or updated for Replimune Group (REPL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on December 6, 2023 so you should expect the next rating to be made available sometime around December 6, 2024.
Is the Analyst Rating Replimune Group (REPL) correct?
While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a maintained with a price target of $50.00 to $13.00. The current price Replimune Group (REPL) is trading at is $6.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.